Mechanism of action is rarely captured by a handful of genes alone. It emerges from coordinated changes across biological pathways.
🎥 Watch the full recording: eu1.hubs.ly/H0xdGkT0#DrugDiscovery#RNAseq
Combining high-content imaging with transcriptomic profiling can provide a more comprehensive view of cellular response, linking phenotypic changes to molecular mechanisms at scale.
Join our talk at SBI²?
#Transcriptomics#HighContentScreening#DrugDiscovery
Celebrating 6 years of Alithea Genomics 🥂
From a small team to a global provider of high-throughput transcriptomics for drug discovery, crop protection, and academic research. These 6 years have been about growth, innovation, teamwork, and impact.
#transcriptomics#rnaseq
MERCURIUS™ 1536 DRUG-seq brings DRUG-seq into native 1536-well workflows, so teams can generate transcriptome-wide compound-response data at a scale that matches the needs of foundational AI-models for drug-discovery.
More details on our website: eu1.hubs.ly/H0w8DBS0
We are very happy to announce a new agreement with Revvity Inc. to broaden access to MERCURIUS™ DRUG-seq and MERCURIUS™ Total DRUG-seq solutions through Revvity’s global commercial network.
Read more here: eu1.hubs.ly/H0v_J5w0
Join us at booth #807 at SOT 2026 if you want to talk through how transcriptomics and Cell Painting can advance your toxicology pipelines.
Explore our three themes to watch at SOT 2026 with recommended sessions in the link below: eu1.hubs.ly/H0sXx-K0
How do you capture sufficient biological complexity in compound safety assessment to enable more informed decisions?
Find out at the @SOT Annual Meeting this week.
March 23rd, 9:00–11:45, Poster Board F493, ToxExpo Hall B.
Come meet the Alithea Genomics team at #SLAS2026 at Booth #2539. We are unveiling MERCURIUS™ 1536 DRUG-seq for the first time.
Talk:
🎤 Automation-Ready 1536 DRUG-seq: High-Content Transcriptomics at Screening Scale
🗓️ Wednesday, Feb 11 | ⏰ 1:00 PM (local) | 📍 Boston
PAG 33 is in full swing, and our team is looking forward to talking to you at Booth #527 🌿🧬
🎤 Don't miss our joint session with Bayer today! (Mon, Jan 12 | 4:00–6:10 PM | Pacific C)
#PAG33#Transcriptomics#RNAseq
Wrapping up 2025 with two offers to squeeze a bit more science out of your budget:
🧪 New: 30% off DRUG-seq, BRB-seq and FLASH-seq kits
🎉 Reminder: Free NGS sequencing on RNA-seq services
More details on our website eu1.hubs.ly/H0qdw8Y0#RNAseq#NGS#Transcriptomics
Before you get overwhelmed with all the Black Friday promo deadlines… Just remember that our free sequencing offer is valid until the end of the year.
Learn More: eu1.hubs.ly/H0q0dr90
🌱 Pharma already emits 55% more CO₂e per dollar of revenue than the automotive industry, and single-use lab plastics are a growing part of the story.
More details in our blog:
👉 eu1.hubs.ly/H0p-3GM0
Approximately one-third of drug candidates fail in the first phase of clinical trial because of undetected toxicity.
Check out our new blog post to explore how the OASIS Consortium is advancing safety science:
eu1.hubs.ly/H0pL7xY0
From now until December 31st, 2025, get FREE NGS sequencing when you order our RNA-seq service. Generate deeper, more meaningful transcriptomic data without additional sequencing costs!
More details here: eu1.hubs.ly/H0pFy-T0
We counted: 200 BRB-seq kits + 12 BRB-seq Giga kits = 1 exhausted label printer, 3 empty coffee pots, and a very happy customer.
Shipped yesterday from our US lab.
Proud of this team for turning caffeine into throughput. ☕️➡️📦